TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias” September 9, 1994